Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1989
Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in normal-weight menM M Ritter, W O Richter, P SchwandtJournal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|August 1, 1983
Comparison of 20-oxosteroids and cortisol in urine as parameters of adrenocortical functionM M Ritter, H M Liebich, M RadjaipourFortschritte Der Medizin|October 10, 1992
[Effects of beta blockers on lipoprotein metabolism]M M Ritter, W O Richter, P SchwandtAtherosclerosis. Supplements|May 5, 2015
Effects of lipoprotein apheresis on PCSK9 levelsU Julius, M Milton, D Stoellner, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 17, 2009
In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registryK G Parhofer, U Zeymer, R G Stark, et al.Archives of Gynecology and Obstetrics|July 23, 2013
Gestational diabetes in Turkmenistan: implementation of a screening program and first resultsK G Parhofer, U Hasbargen, A Ulugberdiyewa, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1990
Short- and long-term effects of LDL-apheresis on lipoprotein (a) serum levelsM M Ritter, K Sühler, W Richter, et al.Diabetes & Metabolism|October 13, 2015
Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA StudyD Simon, P de Pablos-Velasco, K G Parhofer, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein BC A Aguilar-Salinas, P H Barrett, K G Parhofer, et al.Diabetes & Metabolism|July 25, 2013
Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferencesA F Mohamed, J Zhang, F R Johnson, et al.Pageof 12